BIS icon

ProShares UltraShort NASDAQ Biotechnology

7 hedge funds and large institutions have $1.99M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
6
Closed
2
Calls
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$4K
Name Market Value Shares Shares
Change
Shares
Change %
HF
1
HRT Financial
New York
$928K 29,990 +2,645 +10%
WP
2
WealthSource Partners
California
$590K 19,050 -49,950 -72%
Citadel Advisors
3
Citadel Advisors
Florida
$254K 8,207 -24,138 -75%
Simplex Trading
4
Simplex Trading
Illinois
$203K 6,559 -2,184 -25%
Morgan Stanley
5
Morgan Stanley
New York
$12K 381 -259 -40%
TRCT
6
Tower Research Capital (TRC)
New York
$3K 102 -41,494 -100%
Citigroup
7
Citigroup
New York
$3K 85 -255 -75%
LC
8
Lindbrook Capital
California
-9,000 Closed
CG
9
Cutler Group
California
-2,399 Closed
IA
10
IFP Advisors
Florida
CFGS
11
Concourse Financial Group Securities
Alabama